Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1996
12/05/1996WO1996038564A1 Dna sequences of banana bunchy top virus
12/05/1996WO1996038563A1 HIGH METHIONINE DERIVATIVES OF α-HORDOTHIONIN
12/05/1996WO1996038562A1 HIGH THREONINE DERIVATIVES OF α-HORDOTHIONIN
12/05/1996WO1996038561A1 Improved methods of producing feed by reducing endogenous protein levels in soybean
12/05/1996WO1996038560A2 Genetic control of flowering
12/05/1996WO1996038559A1 Chemokine n-terminal deletion mutations
12/05/1996WO1996038558A2 A human purinergic p2u receptor
12/05/1996WO1996038556A2 Deltap62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer
12/05/1996WO1996038555A2 Unc-53 from c. elegans and its uses in testing compounds involved in the control fo cell behaviour and pharmaceutical compositions
12/05/1996WO1996038540A1 Dna encoding cellular homologue of the sv40 large t antigen
12/05/1996WO1996038480A1 Anti-inflammatory thrombospondin-derived peptides
12/05/1996WO1996038479A1 Method of diagnosis of insulin dependent diabetes melitus and kit to be used therein
12/05/1996WO1996038478A1 New dna molecules
12/05/1996WO1996038477A1 Novel antiproliferative protein from bacillus thuringiensis var. thuringiensis
12/05/1996WO1996038476A1 Haemophilus influenzae pilus vaccines
12/05/1996WO1996038475A1 Helicobacter pylori antigens and vaccine compositions
12/05/1996WO1996038474A2 Diagnosis of, and vaccination against, a positive stranded rna virus using an isolated, unprocessed polypeptide
12/05/1996WO1996038473A2 Antimicrobial cationic peptides
12/05/1996WO1996038467A1 Fragile x related proteins, compositions and methods of making and using the same
12/05/1996WO1996038463A1 Dna sequence and encoded mammary-specific breast cancer protein
12/05/1996WO1996038462A1 Regulators of g-protein signalling
12/05/1996WO1996038178A1 Allogeneic and xenogeneic transplantation
12/05/1996WO1996038177A1 Mutants of salmonella typhi and uses thereof
12/05/1996WO1996038172A1 Connective tissue growth factor
12/05/1996WO1996038171A1 Methods of raising antibodies against e.coli of the family cs4-cfa/1
12/05/1996WO1996038168A1 Methods and uses of connective tissue growth factor as an induction agent
12/05/1996WO1996038167A1 Use of fibroblast growth factors to stimulate bone growth
12/05/1996WO1996038164A1 Serum immunoregulatory polypeptides and uses therefor
12/05/1996WO1996034966A3 Engineering protein posttranslational modification in transgenic organisms
12/05/1996WO1996034953A3 Cd16-ii variants
12/05/1996WO1996034884A3 Synthetic peptides of m. gallisepticum, antibodies thereto, their preparation and use
12/05/1996WO1996034099A3 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
12/05/1996WO1996031603A3 Methods and compositions for regulating fadd
12/05/1996DE19520421A1 Thrombosis-associated autoantigen
12/05/1996CA2741641A1 Antibody specific for a mammaglobin polypeptide
12/05/1996CA2222968A1 Diagnosis of, and vaccination against, a positive stranded rna virus using an isolated, unprocessed polypeptide
12/05/1996CA2222863A1 Serum immunoregulatory polypeptides and uses therefor
12/05/1996CA2222797A1 Helicobacter pylori antigens and vaccine compositions
12/05/1996CA2222655A1 Chemokine n-terminal deletion mutations
12/05/1996CA2222615A1 High threonine derivatives of .alpha.-hordothionin
12/05/1996CA2222609A1 Methods and uses of connective tissue growth factor as an induction agent
12/05/1996CA2222600A1 High methionine derivatives of .alpha.-hordothionin
12/05/1996CA2222599A1 Antimicrobial cationic peptides
12/05/1996CA2222526A1 A method of expressing and secreting soluble extracellular domains of human gonadotropin hormone receptors
12/05/1996CA2222419A1 A novel form of dipeptidylpeptidase iv (cd26) found in human serum, antibodies thereto, and uses therefor
12/05/1996CA2222409A1 Method for the detection of compounds that modulate the effects of the obese protein
12/05/1996CA2221621A1 Methods and compositions for identifying osteogenic agents
12/05/1996CA2220955A1 A novel human purinergic p2u receptor
12/05/1996CA2220530A1 Improved method for obtaining full-length cdna sequences
12/05/1996CA2219861A1 .delta.p62, variants thereof, nucleic acid sequences and uses thereof
12/04/1996EP0745852A1 Use of functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy
12/04/1996EP0745674A2 Helicobacter polypeptides, their production and use
12/04/1996EP0745672A2 Production of recombinant factor VIII in the presence of liposome-like substances of mixed composition
12/04/1996EP0745669A2 Mutant staphylococcus aureus V8 proteases
12/04/1996EP0745611A1 Interleukin-4 and Interleukin-1beta synergistically induce VCAM-1
12/04/1996EP0745610A2 Process for preparing anti-obesity protein
12/04/1996EP0745602A1 Quinidine immunoassay and reagents
12/04/1996EP0745386A1 Anti-aids secretory recombinant bcg vaccine
12/04/1996EP0745136A1 B7-1-specific ligands, and their use for the induction of t cell anergy
12/04/1996EP0745134A1 Nucleic acid delivery system, method of synthesis and uses thereof
12/04/1996EP0745133A1 Recombinant infectious bovine rhinotracheitis virus s-ibr-052 and uses thereof
12/04/1996EP0745132A1 Method for preparing orphan receptor ligands
12/04/1996EP0745130A1 Heterologous g protein coupled receptors expressed in yeast, their fusion with g proteins and use thereof in bioassay
12/04/1996EP0745129A1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
12/04/1996EP0745128A1 Hepatitis b virus mutants, reagents and methods for detection
12/04/1996EP0745127A1 Control of marek's disease by the inhibition of latency and tumor cell development
12/04/1996EP0745126A1 High lysine derivatives of alpha-hordothionin
12/04/1996EP0745125A1 Hematopoietic protein and materials and methods for making it
12/04/1996EP0745124A1 Mammalian cell cycle protein
12/04/1996EP0745123A1 pp32: A NEWLY IDENTIFIED CD45-ASSOCIATED PROTEIN
12/04/1996EP0745122A1 Galanin receptor, nucleic acids, transformed cells and uses thereof
12/04/1996EP0745121A1 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
12/04/1996EP0745095A1 Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor
12/04/1996EP0745094A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection
12/04/1996EP0745093A1 New oligopeptides with affinity to opioid receptors
12/04/1996EP0744959A1 Treatment of antibiotic associated diarrhea
12/04/1996EP0744956A1 Peptides and methods against diabetes
12/04/1996EP0744953A1 Erythropoietin analog compositions and methods
12/04/1996EP0744901A1 Isolation of lactoferrin from milk
12/04/1996EP0744891A1 Transgenic fibrinogen
12/04/1996EP0479920B1 Novel antibodies reactive with human carcinomas
12/04/1996CN1137294A Use of alpha-1,4-glucan lyase for preparation of 1,5-D-anhydrofructose
12/04/1996CN1137292A Purification of vitamin-K dependent proteins by membrane chromatography
12/04/1996CN1137040A New mercaptoalanoyldipeptide compounds process for their preparation and pharmaceutical compositions containign them
12/04/1996CN1136960A Polyamines and polypeptides useful as antagonisis of excitatory amino acid neurotransmitiers and/or as blockers of calcium channels
12/03/1996US5581476 Computer-based methods and articles of manufacture for preparing G-CSF analogs
12/03/1996US5580968 Useful in diagnosing and following the course of rheumatoid arthitis
12/03/1996US5580967 Optimized catalytic DNA-cleaving ribozymes
12/03/1996US5580963 Proteolysis resistance
12/03/1996US5580962 Purification of activated protein c by ion exchange chromatography to remove serum amyloid p, antibodies and thrombin-inhibitor complex, then inactivating viruses
12/03/1996US5580961 Heterodimeric T lymphocyte receptor subunit
12/03/1996US5580960 KS-laminin and methods of use
12/03/1996US5580959 Purification of zein from corn gluten meal
12/03/1996US5580958 Dna binding protein
12/03/1996US5580955 Polypeptide
12/03/1996US5580954 Anti-obesity proteins
12/03/1996US5580953 Useful in therapy of type 2 diabetes mellitus, impaired glucose tolerance, obesity and insulin resistance
12/03/1996US5580859 Biological injections into mamalian muscle of dna to express a therapeutic protein, polypeptide or peptide; vaccines; administering a dystrophin gene correcting muscular dystrophy
12/03/1996US5580856 Formulation of a reconstituted protein, and method and kit for the production thereof
12/03/1996US5580853 Erythropoietin with attached heterobifunctional crosslinking reagent containing cleavable disulfide bond group